How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Bromacil Market
- By Formulation Type: Granular, Liquid Concentrate, Wettable Powder, Soluble Powder
- By Application Method: Soil Application, Foliar Application, Pre-emergence Application, Post-emergence Application
- By Crop Type: Citrus, Sugarcane, Corn, Ornamentals, Non-crop Areas
- By Packaging Type: Plastic Containers, Metal Drums, Flexible Intermediate Bulk Containers (FIBCs), Bags
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Granular leads By Formulation Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 272 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 14 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Bromacil Market report
A complete, evidence-based study - 11 chapters and 114 sections covering market size, segmentation across 4 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Formulation Type 4
Application Method 4
Crop Type 5
Packaging Type 4
Companies profiled
BASF SE
Syngenta AG
Nufarm Limited
ADAMA Agricultural Solutions Ltd.
UPL Limited
Bayer Crop Science
Corteva Agriscience
Sumitomo Chemical Co. Ltd.
Nippon Soda Co. Ltd.
Mitsui Chemicals Inc.
Arysta LifeScience Corporation
FMC Corporation
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →ADAMA Agricultural Solutions Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →UPL Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Bayer Crop Science
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Corteva Agriscience
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sumitomo Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nippon Soda Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mitsui Chemicals Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Arysta LifeScience Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →FMC Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Sharda Cropchem Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Inovyn
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$966.5M by 2033 · 3.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Granular51.8
- Liquid Concentrate19.0
- Wettable Powder13.0
- Soluble Powder16.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$245.3M → $291.2M · 2.2%
Europe$170.9M → $206.3M · 2.4%
Asia Pacific$156.1M → $210.9M · 3.8%
Latin America$96.6M → $112.4M · 1.9%
Middle East and Africa$74.3M → $87.9M · 2.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.282026
3.312027
3.302028
3.332029
3.342030
3.342031
3.362032
3.382033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE20.5
- Syngenta AG16.0
- Nufarm Limited9.5
- ADAMA Agricultural Solutions Ltd.10.8
- UPL Limited9.5
- Bayer Crop Science5.9
- Others27.8
Segment contribution to growth (%)
Fig. 18 · p.39 →Formulation Type42.8%
Application Method19.5%
Crop Type18.0%
Packaging Type19.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe22.7
- Asia Pacific23.2
- Latin America12.4
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 78 | 94 | 86 | 93 | 90 | 80 | 87 |
| Syngenta AG | 84 | 75 | 71 | 71 | 91 | 88 | 80 |
| Nufarm Limited | 86 | 82 | 72 | 69 | 70 | 81 | 77 |
| ADAMA Agricultural Solutions Ltd. | 79 | 74 | 62 | 78 | 74 | 79 | 74 |
| UPL Limited | 64 | 73 | 63 | 64 | 77 | 64 | 68 |
| Bayer Crop Science | 70 | 67 | 58 | 58 | 50 | 66 | 62 |
| Corteva Agriscience | 60 | 51 | 55 | 55 | 42 | 48 | 52 |
| Sumitomo Chemical Co. Ltd. | 35 | 58 | 53 | 45 | 51 | 43 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Syngenta AG
- Nufarm Limited
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Syngenta AG | ◐ | ✓ | ✓ | − | ◐ | ✓ |
| Nufarm Limited | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| ADAMA Agricultural Solutions Ltd. | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| UPL Limited | ◐ | ◐ | − | ◐ | ✓ | − |
| Bayer Crop Science | − | ◐ | ◐ | ◐ | − | ◐ |
| Corteva Agriscience | ◐ | ◐ | − | − | − | ◐ |
| Sumitomo Chemical Co. Ltd. | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE87
2Syngenta AG80
3Nufarm Limited77
4ADAMA Agricultural Solutions Ltd.74
5UPL Limited68
6Bayer Crop Science62
7Corteva Agriscience52
8Sumitomo Chemical Co. Ltd.48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SESyngenta AG
Challenger3
Strong scale, closing on the leaders.
Nufarm LimitedADAMA Agricultural Solutions Ltd.UPL Limited
Contender1
Focused players with pockets of strength.
Bayer Crop Science
Niche2
Specialists in a single segment or region.
Corteva AgriscienceSumitomo Chemical Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Formulation Type in North America, then scale across Bromacil Market — a $412M beachhead inside a $6.75B market.
Beachhead (SOM)$412Mobtainable near-term
Serviceable (SAM)$2.73Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Granular
Best fit — highest urgency & budget in Formulation Type.
Economic buyer80 fit
Liquid Concentrate
Strong fit — clear ROI and a fast path to value.
End user66 fit
Wettable Powder
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Formulation Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application Method & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Crop Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve22%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Formulation Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bromacil Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified26%
Evaluation12%
Closed-won6%
$17.4KCAC
$60KLTV
3.4:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bromacil Market is a durable-growth opportunity — $921M by 2033, compounding at 8.0%.
TAM · 2025$497Mtoday
TAM · 2033$921Mforecast
CAGR8.0%2027–2033
Cumulative$6.21Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$921MTotal addressable market
SAM$334MServiceable available market
SOM$62MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.0% CAGR
Demand compounds through 2033, outpacing GDP across Formulation Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Formulation Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$921MLarge & growingTAM by 2033 at 8.0% CAGR
$334MServiceable nowreachable with today’s model
$62MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$718MBear5.2% CAGR
$921MBase8.0% CAGR
$1.18BBull10.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application Method optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bromacil Market — a $7.52B market by 2033. Plan: grow share from 9.0% to 18.1%.
Market size · 2033$7.52Btotal addressable
Market CAGR5.3%2027–2033
Target share18.1%from 9.0% today
Revenue ambition$1.36Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.0% | 18.1% | On track |
| Revenue | $695M | $1.36B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 34.8% | 38.1% | On track |
| Customer retention | 88.8% | 92.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Formulation Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application Method capability
A defensible second engine — invest in Application Method to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Formulation Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application Method
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $137M capacity & capability investment
- Greenlight bolt-on M&A in Application Method
- Authorise North America expansion plan
- Fund R&D program for Formulation Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bromacil Market conversation — a $5.78B market you can size, segment and defend in minutes.
Market size · 2033$5.78Btotal opportunity
Growth9.4%CAGR to 2033
Addressable buyers1,036+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Formulation Type
Goal Grow share in Formulation Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 3 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
BASF SESyngenta AGNufarm LimitedADAMA Agricultural Solutions Ltd.UPL LimitedBayer Crop ScienceCorteva AgriscienceSumitomo Chemical Co. Ltd.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bromacil Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bromacil Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →Synthetic and Bio-based PMMA (Polymethyl Methacrylate) Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportUltraviolet (UV) Curable Inks Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportGen 8.5 Substrate Glass Market
Market size, share, segmentation and regional forecast.
$632M market · 2025 base year
View reportGemstone Sorters Market
Market size, share, segmentation and regional forecast.
$309M market · 2025 base year
View reportGem Stone Processing Services Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportGem-Quality Synthetic Diamond Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportGem-Quality Lab-Grown Diamonds Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportGel Type Anion Exchange Resin Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportGel Strength Test Systems Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportGel Staining Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportGel Seal Type HEPA Filter Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportGel Seal HEAP Filter Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.